Literature DB >> 17222998

The routine use of C-reactive protein in forensic investigations.

B S Astrup1, J L Thomsen.   

Abstract

In clinical medicine, C-reactive protein (CRP) is extensively used as a general marker for immune system activation, and post-mortem applicability has been established [M.Q. Fujita, B.L. Zhu, K. Ishida, L. Quan, S. Oritani, H. Maeda, Serum C-reactive protein levels in postmortem blood-an analysis with special reference to the cause of death and survival time, Forensic Sci. Int. 130 (2002) 160-166; L. Uhlin-Hansen, C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels, Forensic Sci. Int. 124 (2001) 32-35]. We have analysed the routine use of CRP in non-selected cases. Scarcity of blood available for analysis is a common problem in forensic investigation, and in response to this we have developed a method using liver as a source. In 50 consecutive autopsy cases, we have evaluated method, validated results and discussed their interpretation. In three cases the analysis was not possible. For each of the remaining cases (n=47) we have analysed whole blood, serum and/or liver samples. 57% (n=25) had serum CRP > 10 mg/L. Serum levels were higher than in whole blood or liver. CRP levels in serum and whole blood samples were stable in more than one month after death, making storage for later analysis possible. Liver levels peaked at one week, but after one month putrefaction was obvious. CRP levels were independent of the post-mortem interval. The use of liver as a source has not yet been described in literature. Our results in liver samples correlate well with plasma results, and liver is a good post-mortem alternative when blood is not available. We conclude that CRP measurements are easy, viable and inexpensive in a forensic setting, and that the number of cases with CRP elevation is high in a non-selected forensic material. In cases of doubt, marked elevation of CRP is an indicator of natural mode of death, and in cases of trauma, it indicates vital reaction. It can be used as a pre-autopsy screening, leading to a more extensive search for diseases not easily diagnosed, such as sepsis or ketoacidosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222998     DOI: 10.1016/j.forsciint.2006.10.021

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  12 in total

1.  Procalcitonin and C-reactive protein in pericardial fluid for postmortem diagnosis of sepsis.

Authors:  Bettina Schrag; Katia Iglesias; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-03-29       Impact factor: 2.686

Review 2.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

3.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

4.  Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities.

Authors:  Bettina Schrag; Pascale Roux-Lombard; Deborah Schneiter; Paul Vaucher; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2011-07-07       Impact factor: 2.686

Review 5.  Systematic Review on Post-Mortem Protein Alterations: Analysis of Experimental Models and Evaluation of Potential Biomarkers of Time of Death.

Authors:  Matteo Antonio Sacco; Fabrizio Cordasco; Carmen Scalise; Pietrantonio Ricci; Isabella Aquila
Journal:  Diagnostics (Basel)       Date:  2022-06-17

6.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

7.  Preliminary results on the postmortem measurement of 3-beta-hydroxybutyrate in liver homogenates.

Authors:  Cristian Palmiere; Patrice Mangin; Dominique Werner
Journal:  Int J Legal Med       Date:  2013-05-31       Impact factor: 2.686

8.  Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.

Authors:  Benjamin Ondruschka; Lina Woydt; Michael Bernhard; Heike Franke; Holger Kirsten; Sabine Löffler; Dirk Pohlers; Niels Hammer; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-08-30       Impact factor: 2.686

Review 9.  Markers for sepsis diagnosis in the forensic setting: state of the art.

Authors:  Cristian Palmiere; Marc Augsburger
Journal:  Croat Med J       Date:  2014-04       Impact factor: 1.351

10.  Evaluation of Point-of-Care Testing for C-Reactive Protein in Forensic Medicine.

Authors:  Joo Young Na; Jong Tae Park
Journal:  J Korean Med Sci       Date:  2019-10-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.